Left ventricular hypertrophy is associated with an increased cardiovascular mortality in hypertension. A potential role of ventricular arrhythmias is debated but not yet determined. The purpose of this study was to evaluate whether the presence of arrhythmias would ascribe any additional risk to cardiovascular mortality beyond that related to the presence of left ventricular hypertrophy. From November 1988 to February 1991, 40 mild to severe hypertensive patients (mean SBP, DBP 183/117 mm Hg) were submitted to clinical, echocardiographic and electrocardiographic evaluations complemented by 24-h Holter monitoring and then followed until November 1996. The Kaplan-Meier method supplemented by the Cox multiple regression model were performed to identify the variable(s) associated with fatal cardiovascular outcome. Twelve cardiovascular fatalities occurred as a consequence of sudden death (n ‫؍‬ 4), stroke (n ‫؍‬ 4), heart failure (n ‫؍‬ 2) and myocardial infarction (n ‫؍‬ 2). In comparison with patients who
Introduction
Hypertension has long been recognised as one of the main risk factors for cardiovascular morbidity and mortality. More recently, data obtained from the Framingham Heart Study have revealed a significant association between left ventricular hypertrophy and cardiovascular fatalities, an association independent of blood pressure levels. 1 In addition, several studies have reported an increased prevalence of hypertensive patients with asymptomatic ventricular arrhythmias associated with the presence and the degree of left ventricular hypertrophy. [2] [3] [4] However, it has not yet been determined whether an increase in either frequency or complexity of ventricular arrhythmias is related to a fatal outcome in hypertensive subjects, such as the relationship shown in patients with ischaemic heart disease 5, 6 and hypertrophic cardiomyopathy. 7, 8 The present long-term prospective study was undertaken to evaluate the particular role of ventricular arrhyth- mias, as opposed to left ventricular hypertrophy, in cardiovascular mortality of patients with hypertension.
Material and methods
All procedures were carried out in accordance with institutional guidelines and the protocol was approved by our institutional review committee. Between November 1988 and February 1991, 43 patients with mild to severe essential hypertension were selected and gave informed consent for entering the study. Patients underwent complete clinical and biochemical evaluations, including casual blood pressure determinations. Patients with a suggestive history of ischaemic heart disease, valvular heart disease, diabetes, alcohol abuse, renal failure with creatinine levels above 2 mg/dl and other metabolic diseases were excluded. Antihypertensive drugs were withdrawn 2 weeks before enrolment in 33 patients to avoid hypothetical interference of antihypertensive therapy on cardiac rhythm. Clinical status of the remaining 10, all with severe hypertension, including four patients with a previous history of congestive heart failure, precluded the interruption of antihypertensive treatment for ethical reasons. Neither one of them, however, was receiving beta-blockers, digitalis or angiotensinconverting enzyme inhibitors before the study. After completing Holter monitoring, the medications were restarted. Basically, a diuretic (hydrochlorothiazide) was the first drug employed, followed by an adrenergic inhibitor (methyldopa or propranolol) and a vasodilator (hydralazine). Potassium supplements, potassium-sparing diuretic (amiloride), angiotensinconverting inhibitors and loop diuretics were added as necessary.
All patients underwent standard 12-lead electrocardiogram. Electrocardiographic left ventricular hypertrophy and strain were established based on the presence voltage criteria SV1 + RV5 Ͼ3.5 mV and ST depression of у0.05 mV associated to Twave inversion of у0.1 mV in leads I, aVL and V5 or V6.
Echocardiographic study
M-mode two-dimensionally guided tracings were obtained using an ALOKA SSD 870 equipment and 2.5 and 3.5 MHz transducers. The following parameters were determined, based on the recommendations of the American Society of Echocardiography:
9 left ventricular end-diastolic (LVID) and endsystolic (LVIS) internal diameters and left ventricular end-diastolic posterior wall (PWTd) and interventricular septal thickness (IVSTd) and end-systolic posterior wall thickness (PWTs). Left ventricular mass was calculated based on the following formula, normalised by body surface area to obtain left ventricular mass index 10, 11 :
Left ventricular fractional shortening (LVFS) was calculated as follows 12 :
Left ventricular end-systolic meridional wall stress (LVESS) was calculated based on a previously validated non-invasive method, 13, 14 in which cuff systolic blood pressure (SBP), obtained during left ventricular tracing recordings, is employed as corresponding to left ventricular peak-systolic pressure:
Ambulatory ECG monitoring
Immediately after the echocardiographic study a 24-h ECG monitoring was undertaken during each patients' normal daily activities. ECG tracings were recorded by two bipolar leads and analysed in a Marquette Laser 8000 XT equipment by an experienced technician.
The presence of frequent or complex ventricular arrhythmias was defined according to either one of the following three criteria: (1) number of ventricular ectopic beats Ͼ10 per hour, (2) presence of couplets, and (3) presence of episodes of non-sustained ventricular tachycardia, characterised as Ͼ3 consecutive ventricular ectopic complexes occurring at a rate of Ͼ100 beats/min. The frequency of Ͼ10 ventricular ectopic beats per hour was selected based on the observations showing that at this rate the mortality of a postinfarction population reaches a plateau. 15 Multiform ventricular ectopic beats and R-on-T complexes were not contemplated, since they were shown to have little significance on prognosis. 16 Patients with frequent or complex ventricular arrhythmias who gave informed consent were submitted to coronary angiography to rule out a significant (Ͼ70%) coronary artery obstruction that could likely imply the rhythm disturbances to myocardial ischaemia.
Cardiovascular mortality was selected as the endpoint of the study. The causes of fatalities occurring outside our institution were determined with the help of a metropolitan database system on mortality in São Paulo and further substantiated by phone or personal contacts with first degree relatives. The circumstances of sudden deaths (up to 1 h after the beginning of the symptoms) occurring outside medical facilities were attested by contacted persons who directly witnessed the events.
Follow-up was undertaken every 2 weeks until blood pressure control and subsequently at a 2-month interval, unless otherwise necessary. The ending of study was settled to November 1996 to ensure all enrolled patients had a minimum 5-year follow-up.
Statistical analysis
Quantitative variables are reported as means ± standard deviation and qualitative variables as percentages. Clinical baseline characteristics of patients separated as survivor and non-survivor groups were compared using two-tailed unpaired t-test and chisquare test when appropriate, 17 considering the Pvalue 0.05 as statistically significant. Survival curves were estimated by the KaplanMeier product-limit method. 18 The log-rank test was used for statistical comparisons between the survival probability curves of each of the following qualitative variables: gender, the presence of electrocardiographic left ventricular hypertrophy and strain and the presence of frequent or complex ventricular arrhythmias as defined above or the presence of either one of the three criteria contemplated separately. In addition, the log rank tests for the association of survival times with each continuous variable such as age, systolic and diastolic blood pressure, left ventricular mass index, left ventricular fractional shortening and left ventricular end-systolic wall stress were computed. 18 Multivariate survival analysis was made with the Cox proportional hazards model to determine which variables were independently associated with cardiovascular mortality. 18 The variables chosen for entering the model were those with P Ͻ 0.10 in the univariate model. The stepwise selection method was used considering as significant the P-values of 0.05 and 0.15 to remove a variable from or to enter it into the model, respectively. Results are expressed as risk ratio with 95% confidence intervals.
Results
Three from the original cohort of 43 patients lost follow-up during the first 3 months and were excluded. The remaining 40 (25 men and 15 women), aged 45.05 ± 11.61 years, fulfilled the inclusion criteria. Sixteen patients were in hypertension stage I or II and 24 in stage III. 19 The average measured blood pressure at the time of the echocardiographic study was 183 ± 29 mm Hg and 117 ± 18 mm Hg for systolic and diastolic blood pressure, respectively. Serum potassium levels were in the normal range in all (mean: 4.21 ± 0.34 mEq/L).
Half of the patients met the electrocardiographic criteria for left ventricular hypertrophy and 18 of them showed the strain pattern of repolarization.
Mean ). The average number of ventricular ectopic beats during 24-h Holter monitoring was 73 ± 182 per hour. Sixteen patients were characterised as having frequent or complex ventricular arrhythmias. Eleven of them had Ͼ10 ventricular ectopic beats per hour, 12 showed at least one ventricular couplet. Six patients had runs of non-sustained ventricular tachycardia, half of them with Ͼ3 beats per episode. The number of episodes of non-sustained ventricular tachycardia ranged from one to three in most patients. A single patient with 188 runs of non-sustained ventricular tachycardia died of heart failure aggravated by end-stage renal failure 13 months after entering the study. His longest recorded run was 20 beats.
Coronary angiography was performed in 12 out of the 16 patients with frequent or complex ventricular arrhythmias. In only two a у70% coronary obstruction was found. One patient was found to have single-vessel disease and the other one had three-vessel disease. Both were alive and uneventful at the end of the study.
The mean duration of follow-up of the entire population studied was 73 ± 24 months. There were 12 fatalities which occurred after 53 ± 32 months (range: 4 to 93). Deaths were sudden in four, and in the remaining eight were the result of cerebrovascular stroke (n = 4), myocardial infarction (n = 2) and heart failure (n = 2). In the survivor cohort there were four additional significant morbid events, two of them cardiovascular in nature: a cerebrovascular stroke and a case of unstable angina followed by myocardial infarction. A myelodysplasia occurred in an additional patient who was still alive at the end of the study while another one died of urinary bladder cancer 3 years after enrolment.
The comparison of the baseline clinical characteristics of the patients according to the cardiovascular outcome is depicted in Table 1 . As a whole it can be noticed that patients who survived showed a less pronounced impairment in cardiovascular status. The estimate of the survival probability for the entire population studied is shown in Figure 1 . In univariate analysis electrocardiographic left ventricular hypertrophy and strain, left ventricular mass index, left ventricular end-systolic wall stress, left ventricular fractional shortening and the presence of couplets were significantly related to cardiovascular death. Frequent or complex ventricular arrhythmias as a whole or the presence of either Ͼ10 ventricular ectopic beats per hour or episodes of non-sustained ventricular tachycardia taken into account separately failed to predict a fatal cardiovascular outcome (Table 2 ).
Cox's proportional hazards model performed after the stepwise selection of the variables which were found to be significant in the univariate analysis identified left ventricular mass index as the unique parameter related to a fatal cardiovascular outcome. In fact, a 20 g/m 2 difference in left ventricular mass index corresponds to a risk ratio of 1.30 (e 20×0.013 ; 95% confidence interval: 1.005 to 1.021). In Figure 2 , the survival curves estimated from different values of left ventricular mass index are shown. 
Discussion
Since the first report by Messerli et al, 2 several studies have indicated that patients with left ventricular hypertrophy are more likely to develop ventricular arrhythmias manifested as frequent ventricular premature beats and runs of non-sustained ventricular tachycardia. 3, 4 However, the pathologic significance of these arrhythmias has not yet been clarified in hypertension since long-term well designed prospective studies are surprisingly missing. As a result, whether or not frequent or complex ventricular premature beats are casually related to cardiac death remains to be established.
In the present prospective study based on a population of 40 patients with mild to severe hypertension and a broad range of cardiac impairment, the potential independent prognostic value of ventricular arrhythmias has not been confirmed over a long lasting follow-up period. According to previous studies, we found that left ventricular mass was the only independent predictive factor to cardiovascular mortality.
Although not large, the number of patients included in the present study was in fact enough, since the population characteristics were associated with a high mortality rate. The sensitivity of a comparative trial of time to death depends more on the proportion of patients who die than on the total number of patients entered into the trial. 20 Furthermore, after studying the residuals, there was no indication of lack of fit of the Cox regression model.
The fact that we did not strictly look after sudden cardiac death but, instead, considered total cardiovascular mortality as the ultimate end-point, could perhaps represent a limitation. However, we believe that one of the main confounding factors that certainly interferes with a correct interpretation of results in studies of this kind is that there are certainly different causes of sudden and unexpected death other than arrhythmias among hypertensives. Indeed, episodes of non-sustained ventricular tachycardia on Holter monitoring were present in only one of our four patients who died suddenly, making it difficult to establish a direct casual relationship between the presence of complex ventricular arrhythmias and subsequent death in the remaining three. Sudden deaths are reported to occur only in 4% of patients with hypertrophic cardiomyopathy, 7, 8 markedly in contrast to the high incidence found in our population (10%). This certainly points out to diversified causes other than arrhythmogenic in nature and most likely related to the widespread cardiovascular disease in hypertensives. In this respect, left ventricular mass would more appropriately represent the degree of cardiovascular impairment.
Although the study of Bikkina et al 21 was based on the largest cohort ever published, involving hundreds of patients, all of them with echocardiographically determined left ventricular hypertrophy, their conclusion addressing an independent role of complex ventricular arrhythmias on all-cause mortality must be interpreted with caution. First, save for deaths from coronary heart disease, total cardiovascular mortality was not investigated separately. Second, after adjusting for several clinical variables, the increased risk of all-cause mortality turned out to be marginally significant. Third, the importance of left ventricular hypertrophy as opposed to ventricular rhythm disturbances has not been specifically addressed, since left ventricular hypertrophy was present in all patients. Finally, their conclusions should not be applicable to the entire population of hypertensives, since only less than half of the population studied had definite hypertension.
To date, two studies addressing a direct relationship between ventricular arrhythmias and the occurrence of cardiac events in hypertensive patients with left ventricular hypertrophy have been published. The first one, based on a 3-year follow-up of 150 patients without manifest coronary artery disease, was reported by Zehender et al. 22 They noticed that ventricular arrhythmias, although frequent, were particularly associated with the occurrence of ST segment depressions. Logistic regression analysis identified left ventricular hypertrophy and transient ST segment depressions to be of independent prognostic significance in the prediction of cardiovascular events as opposed to repetitive ventricular ectopic beats.
In the second study, performed by Galinier et al, 23 all-cause mortality was associated with age and nonsustained ventricular tachycardia. However, when only cardiac causes were concerned left ventricular hypertrophy turned out to be a strong predictor of death, quite overtaking the importance of non-sustained ventricular tachycardia (4.2 vs 3.5-fold increase).
Another long-term study of 185 black men with uncomplicated hypertension stressed the importance of left ventricular hypertrophy in addition to systolic blood pressure as independent predictors of cardiovascular events in contrast to the presence of ventricular arrhythmias. 24 Similarly, when we examined our data including non-fatal cardiovascular events, we found comparable results. In this circumstance, Cox multivariate analysis identified mass index and systolic blood pressure as independent predictors of cardiovascular event-free prognosis.
It is well established that ventricular arrhythmias are associated with an increased cardiac mortality in patients with ischaemic heart disease. 5, 6 This fact may give rise to speculations that some of the cardiovascular fatalities that occur in hypertensive patients might be related to asymptomatic coronary atherosclerosis. In this setting, ventricular arrhythmias would merely represent a marker of silent myocardial ischaemia. Nonetheless, it has been demonstrated that mortality, especially cardiac in origin, in hypertensive patients can be better predicted by the presence of coronary artery disease than by episodes of non-sustained ventricular tachycardia. 25 Also, the majority of patients with left ventricular hypertrophy and non-sustained ventricular tachycardia have been proved to be free from significant coronary artery disease. 26, 27 In any event, it remains to be determined whether or not ventricular arrhythmias would be an ominous sign in hypertensive patients apart from the postulated association with ischaemic heart disease.
Keeping this in mind, we tried as much as possible to exclude coronary artery disease as an underlying confounding factor to cardiovascular mortality in the present study. In our cohort, comprising patients without documented coronary artery disease, frequent and complex ventricular arrhythmias were not proved to be related to cardiovascular outcome. Indeed, two of our patients in whom coronary artery disease was confirmed are still alive as opposed to six out of 10 with normal coronary anatomy who died. In addition, three out of four patients with complex ventricular arrhythmias in which the coronary status was unknown are alive. The fourth patient died of stroke associated with end-stage renal failure. Accordingly, we can affirm that in hypertensive heart disease ventricular arrhythmias are not predictive of cardiovascular death in the absence of coronary artery disease.
Another conceivable confounding subject-matter in the present study would be the high prevalence of selected patients with cardiac dysfunction. This fact most likely portrays the characteristics of the population of hypertensive patients of a tertiary health care centre such as our institution. That means that a high percentage of patients are referred because of severe hypertension and poor blood pressure control for an unknown, but certainly long period of time. In these circumstances, target organ damage such as left ventricular hypertrophy and strain and poor systolic function are expected to be more prevalent. As a matter of fact, in the non-survivor cohort there were eight patients with moderate to severe left ventricular dysfunction. On the other hand, in the survivor cohort only five patients had left ventricular dysfunction. Indeed, fractional shortening was significantly related to cardiovascular death in univariate analysis. It has to be noticed as well that the high prevalence of cardiac dysfunction we found may in part be due to the occurrence of afterload mismatch caused by the high levels of blood pressure. 28 Accordingly, fractional shortening was normalised in six patients after blood pressure control during the first year of follow-up.
It could also be disputed that coronary artery disease would be likely more prevalent in patients with cardiac dysfunction and, thus, interfering with the results. Although the primary purpose for submitting patients to coronary angiography was to rule out coronary artery diasease as the cause of ventricular arrhythmias, nine of those patients with associated depressed left ventricular fractional shortening had coronary angiography performed. Significant coronary stenotic lesions were found in only two patients, both already mentioned and belonging to the survivor cohort. When we looked at ventricular arrhythmias we found that seven of the 13 patients with systolic dysfunction had ventricular ectopic beats Ͼ10 beats per hour, eight had couplets and five had episodes of non-sustained ventricular tachycardia, indicating an association between poor left ventricular function and ventricular rhythm disturbances.
However, after stepwise selection of each one of the variables chosen in the univariate model, including fractional shortening, left ventricular mass alone was identified as an independent predictor of cardiovascular mortality by Cox analysis.
In contrast to the prognostic value of ventricular arrhythmias in the setting of hypertrophic cardiomyopathy, 7 the negative results regarding cardiovascular mortality we found might be related to the low grade of the reproducibility of 24-h electrocardiographic monitoring in consistently assessing the complexity of ventricular arrhythmias, particularly in the population of hypertensive patients. In fact, as much as 60% of patients in the study of Zehender et al, 22 showed repetitive ventricular arrhythmias in only one of two Holter studies performed 4 weeks apart.
Other authors suggested that the presence of ventricular arrhythmias are influenced by changes in afterload, 29, 30 which are expected to occur usually in hypertensives. It has been suggested that antihypertensive treatment itself may influence the presence of ventricular arrhythmias. When only nevertreated hypertensives with left ventricular hypertrophy were concerned, the increased prevalence of arrhythmias has not been demonstrated. 31, 32 In addition to the likely influence of the treatment itself, it could be anticipated that never-treated hypertensives may have a shorter duration of hypertension as compared to formerly treated patients in whom the diagnosis is likely to have been established a longer time before.
In our cohort it was neither suitable nor ethical to withdraw medications in all patients. As a result, while in some, studied after drug withdrawal, ventricular arrhythmias could have been brought about by blood pressure elevation, in the remaining it could have been heralded by uninterrupted use of antihypertensive medication. In both cases it becomes clear that supplementary factors may undermine the power of ventricular arrhythmias as predictors of cardiovascular disease during the long-term.
The premature ventricular beat hypothesis assumes that ventricular ectopic beats serve as triggers of the initiation of ventricular tachycardia or fibrillation which should be long-lasting enough to cause death. However, it is rather uncommon to observe episodes of spontaneous or induced sustained ventricular tachycardia or fibrillation in hypertensives. 33 The infrequent occurrence of late potentials indicates that the substrate for sustained arrhythmias is most likely lacking.
It seems, therefore, that asymptomatic ventricular arrhythmias alone are not specific markers for a more severe stage of the hypertensive disease. Otherwise, left ventricular mass, being a more constant pathological alteration, would more precisely emulate the actual cardiovascular status as compared to the transitory rhythm disturbances accompanying hypertensive heart disease.
In the present study, we were able to disclose echocardiographically determined left ventricular mass as the best predictor of long-term outcome, since, when compared to other parameters, it better represents the degree of overall hypertensive cardiovascular damage.
